Chest Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shea, J.
Right arrow Articles by Siefkin, A.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Shea, J.
Right arrow Articles by Siefkin, A.

Chest, Vol 103, 1028-1031, Copyright © 1993 by American College of Chest Physicians

ARTICLES

Survival of patients undergoing Nd:YAG laser therapy compared with Nd:YAG laser therapy and brachytherapy for malignant airway disease

JM Shea, RP Allen, RS Tharratt, AL Chan and AD Siefkin
Division of Pulmonary and Critical Care Medicine, University of California, Davis Medical Center, Sacramento.

Brachytherapy in combination with Nd:YAG laser therapy may add to the duration of survival of the palliative period when compared with laser alone. A retrospective study of patients with inoperable squamous cell carcinoma (SCC) was undertaken to determine if there was a difference in survival between those patients treated with Nd:YAG laser alone and those treated with Nd:YAG laser and brachytherapy. Twenty-two patients were treated with brachytherapy for malignant airway disease at our institution of which 13 had SCC. All patients had previously received treatment with Nd:YAG laser for exophytic disease. Survival was compared with those patients treated with Nd:YAG laser alone for SCC involving the airway. There was no statistical difference between the two groups with regard to age. The duration of survival of patients with SCC of the airway from the first Nd:YAG laser treatment was determined. A significant difference between those patients treated with Nd:YAG laser alone and those patients treated with combined therapy was found (p < 0.001). Brachytherapy may potentiate the duration of survival in patients with SCC involving the airway compared to palliation with Nd:YAG laser alone.


This article has been cited by other articles:


Home page
 Am. J. Respir. Crit. Care Med.Home page
A. Ernst, D. Feller-Kopman, H. D. Becker, and A. C. Mehta
Central Airway Obstruction
Am. J. Respir. Crit. Care Med., June 15, 2004; 169(12): 1278 - 1297.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
J.F. Beamis, H.D. Becker, S. Cavaliere, H. Colt, J.P. Diaz-Jimenez, J.F. Dumon, E. Edell, K.L. Kovitz, H.N. Macha, A.C. Mehta, et al.
ERS/ATS statement on interventional pulmonology: Chairmen: C.T. Bolliger, P.N. Mathur
Eur. Respir. J., February 1, 2002; 19(2): 356 - 373.
[Full Text] [PDF]

Home page
 NEJMHome page
L. M. Seijo and D. H. Sterman
Interventional Pulmonology
N. Engl. J. Med., March 8, 2001; 344(10): 740 - 749.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1993 by the American College of Chest Physicians.